BAO PHARMA-B Cuts Free Float by 0.09% Through HKD 2.84 Million Share Buyback

Bulletin Express07-08

Shanghai Bao Pharmaceuticals Co., Ltd. (BAO PHARMA-B) reported a share repurchase on 8 July 2026, cancelling 0.09% of its outstanding H-share free float in a single trading session.

• Transaction details – Shares repurchased: 145,600 – Price range: HKD 19.08–19.55 per share – Volume-weighted average price: HKD 19.48 – Aggregate consideration: HKD 2.84 million

• Capital structure before and after the buyback – Outstanding H shares (ex-treasury) on 7 July 2026: 154.04 million – Treasury shares on 7 July 2026: 0.28 million – Outstanding H shares after buyback: 153.90 million – Treasury shares after buyback: 0.43 million – Total issued shares unchanged at 154.33 million

• Repurchase mandate utilisation – Mandate date: 26 May 2026 – Authorised limit: 15.43 million shares – Cumulative shares repurchased to date: 430,200 – Utilisation rate: 0.28% of the authorised limit

• Regulatory points – All repurchased shares are being held as treasury stock. – Under Hong Kong listing rules, the company cannot issue new shares or sell treasury shares until 7 August 2026, 30 days after the latest repurchase.

The board confirmed that the transaction complied with Hong Kong Stock Exchange regulations and the terms of the existing repurchase mandate.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1160306991?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-08 19:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160306991","market":"hk","top_or_hot":-1,"title":"BAO PHARMA-B Cuts Free Float by 0.09% Through HKD 2.84 Million Share Buyback","media":"Bulletin Express","content":"<p>Shanghai Bao Pharmaceuticals Co., Ltd. (BAO PHARMA-B) reported a share repurchase on 8 July 2026, cancelling 0.09% of its outstanding H-share free float in a single trading session.</p>\n<p>• Transaction details  \n  – Shares repurchased: 145,600  \n  – Price range: HKD 19.08–19.55 per share  \n  – Volume-weighted average price: HKD 19.48  \n  – Aggregate consideration: HKD 2.84 million</p>\n<p>• Capital structure before and after the buyback  \n  – Outstanding H shares (ex-treasury) on 7 July 2026: 154.04 million  \n  – Treasury shares on 7 July 2026: 0.28 million  \n  – Outstanding H shares after buyback: 153.90 million  \n  – Treasury shares after buyback: 0.43 million  \n  – Total issued shares unchanged at 154.33 million</p>\n<p>• Repurchase mandate utilisation  \n  – Mandate date: 26 May 2026  \n  – Authorised limit: 15.43 million shares  \n  – Cumulative shares repurchased to date: 430,200  \n  – Utilisation rate: 0.28% of the authorised limit</p>\n<p>• Regulatory points  \n  – All repurchased shares are being held as treasury stock.  \n  – Under Hong Kong listing rules, the company cannot issue new shares or sell treasury shares until 7 August 2026, 30 days after the latest repurchase.</p>\n<p>The board confirmed that the transaction complied with Hong Kong Stock Exchange regulations and the terms of the existing repurchase mandate.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BAO PHARMA-B Cuts Free Float by 0.09% Through HKD 2.84 Million Share Buyback</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBAO PHARMA-B Cuts Free Float by 0.09% Through HKD 2.84 Million Share Buyback\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-08 19:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Bao Pharmaceuticals Co., Ltd. (BAO PHARMA-B) reported a share repurchase on 8 July 2026, cancelling 0.09% of its outstanding H-share free float in a single trading session.</p>\n<p>• Transaction details  \n  – Shares repurchased: 145,600  \n  – Price range: HKD 19.08–19.55 per share  \n  – Volume-weighted average price: HKD 19.48  \n  – Aggregate consideration: HKD 2.84 million</p>\n<p>• Capital structure before and after the buyback  \n  – Outstanding H shares (ex-treasury) on 7 July 2026: 154.04 million  \n  – Treasury shares on 7 July 2026: 0.28 million  \n  – Outstanding H shares after buyback: 153.90 million  \n  – Treasury shares after buyback: 0.43 million  \n  – Total issued shares unchanged at 154.33 million</p>\n<p>• Repurchase mandate utilisation  \n  – Mandate date: 26 May 2026  \n  – Authorised limit: 15.43 million shares  \n  – Cumulative shares repurchased to date: 430,200  \n  – Utilisation rate: 0.28% of the authorised limit</p>\n<p>• Regulatory points  \n  – All repurchased shares are being held as treasury stock.  \n  – Under Hong Kong listing rules, the company cannot issue new shares or sell treasury shares until 7 August 2026, 30 days after the latest repurchase.</p>\n<p>The board confirmed that the transaction complied with Hong Kong Stock Exchange regulations and the terms of the existing repurchase mandate.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02659","symbol_name":"宝济药业-B","start_time":0,"source_url":"","article_id":"1160306991","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160306991","pubTimestamp":1783508600,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (BAO PHARMA-B) reported a share repurchase on 8 July 2026, cancelling 0.09% of its outstanding H-share free float in a single trading session. • Transaction...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02659":"宝济药业-B"},"translate_title":"宝药业-B通过284万港元回购股票将自由流通量削减0.09%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02659":1},"content_text":"Shanghai Bao Pharmaceuticals Co., Ltd. (BAO PHARMA-B) reported a share repurchase on 8 July 2026, cancelling 0.09% of its outstanding H-share free float in a single trading session.\n• Transaction details  \n  – Shares repurchased: 145,600  \n  – Price range: HKD 19.08–19.55 per share  \n  – Volume-weighted average price: HKD 19.48  \n  – Aggregate consideration: HKD 2.84 million\n• Capital structure before and after the buyback  \n  – Outstanding H shares (ex-treasury) on 7 July 2026: 154.04 million  \n  – Treasury shares on 7 July 2026: 0.28 million  \n  – Outstanding H shares after buyback: 153.90 million  \n  – Treasury shares after buyback: 0.43 million  \n  – Total issued shares unchanged at 154.33 million\n• Repurchase mandate utilisation  \n  – Mandate date: 26 May 2026  \n  – Authorised limit: 15.43 million shares  \n  – Cumulative shares repurchased to date: 430,200  \n  – Utilisation rate: 0.28% of the authorised limit\n• Regulatory points  \n  – All repurchased shares are being held as treasury stock.  \n  – Under Hong Kong listing rules, the company cannot issue new shares or sell treasury shares until 7 August 2026, 30 days after the latest repurchase.\nThe board confirmed that the transaction complied with Hong Kong Stock Exchange regulations and the terms of the existing repurchase mandate.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1160306991","isCrawlerRequest":true}